Worldwide burden of metabolic risk‐related cardiovascular disease from 1990 to 2021, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021

Documenti analoghi

• Disparities in diabetes burden in China and globally, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021
  di: Min Yin, et al.
  Pubblicazione: (2025)
• Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021
  di: Yujie Pan, et al.
  Pubblicazione: (2025)
• Socioeconomic and mental health inequalities in global burden of type 2 diabetes: Evidence from the Global Burden of Disease Study 2021
  di: Mingling Chen, et al.
  Pubblicazione: (2025)
• Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021
  di: Jun‐Qiao An, et al.
  Pubblicazione: (2025)
• Global, regional and country‐specific burden of chronic kidney disease due to type 1 diabetes mellitus: A systematic analysis of the 2021 global disease burden study
  di: Jianran Sun, et al.
  Pubblicazione: (2025)